When in April 1980, after some 2 years of preparations, our team carried out the first brain
tumor positron emission tomography (PET) study using [18F] 2-fluoro-2-deoxyglucose …

The use of positron-emitting radioisotopes to detect primary brain tumors was reported for
the first time in 1951. 1 In the 1970s, the glucose analogue 18F-fluorodeoxyglucose (FDG) …

10■ APPLIED RADIOLOGY© www. appliedradiology. com June 2007 sensitivity and
specificity were 94% and 77%, respectively (Figure 2). In this study, patients were imaged 35 …

Since 1982, when Di Chiro et al. published their first cancer study using [18F]
fluorodeoxyglucose (FDG) positron emission tomography (PET) to show that FDG uptake …

Normal biodistribution of FDG includes intense physiologic uptake in the brain, which
consumes glucose. The high background therefore makes it difficult to detect the foci taking …

Positron emission tomography (PET) has been available for nearly two decades but it is only
recently that it has been introduced on a wider clinical scale. Advantages of PET are the …

PURPOSE To evaluate the differences between fludeoxyglucose F 18 (FDG) and L-methyl-
11C-methionine (11C-methionine) as tracers for positron emission tomography (PET) in the …

Summary 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) scans in the
first 49 patients referred with either possible brain tumour or brain tumour recurrence were …

Objectives: Despite being in use for nearly two decades, the utility of [18F] 2-fluoro-2deoxy-d-
glucose positron emission tomography (FDG PET) in the evaluation and treatment of brain …

As aggressive neurosurgery and adjuvant therapy have become standard care for most
patients with primary central nervous system (CNS) tumors, limitations of posttreatment …